Our study demonstrates that BYHWD ameliorates Alzheimer's disease pathology by modulating the gut microbiota and suppressing the C/EBPβ–AEP signaling pathway. The gene discussed is LGMN; the disease is early-onset autosomal dominant Alzheimer disease.